hims bpc 157 BPC-157 and Healing Peptides: Hype

Association of homocysteine level with biopsy-proven non-alcoholic fatty liver disease: a meta-analysis

Protocol overview: BPC-157 administered via subcutaneous injection, locally near the affected joint Standard dosing range: 200500 mcg per injection session Treatment duration: 48 weeks of active treatment Follow-up assessments: 6 months and 12 months post-treatment Patients were evaluated using validated pain scales (VAS and KOOS scores) and functional mobility assessments at each follow-up point

This is a general pattern, not a rule

If you feel that youre not getting the desired results, speak with your healthcare provider

80 So, while the results sound good, we have to view them as very low-quality evidence